Group One Trading’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,726
| Closed | -$1.68M | – | 6818 |
|
|
2024
Q2 | $1.26M | Buy |
+29,726
| New | +$1.64M | ﹤0.01% | 1802 |
|
|
2024
Q1 | – | Sell |
-6,363
| Closed | -$402K | – | 7283 |
|
|
2023
Q4 | $471K | Buy |
6,363
+3,041
| +92% | +$199K | ﹤0.01% | 3130 |
|
|
2023
Q3 | $227K | Sell |
3,322
-15,775
| -83% | -$1.34M | ﹤0.01% | 3696 |
|
|
2023
Q2 | $1.79M | Buy |
+19,097
| New | +$1.49M | 0.01% | 1804 |
|
|
2023
Q1 | – | Sell |
-19,139
| Closed | -$1.23M | – | 7403 |
|
|
2022
Q4 | $948K | Sell |
19,139
-34,439
| -64% | -$1.41M | ﹤0.01% | 2461 |
|
|
2022
Q3 | $1.74M | Sell |
53,578
-26,111
| -33% | -$1.08M | ﹤0.01% | 2038 |
|
|
2022
Q2 | $3.14M | Buy |
79,689
+23,702
| +42% | +$1.27M | ﹤0.01% | 1648 |
|
|
2022
Q1 | $3.92M | Buy |
55,987
+23,606
| +73% | +$1.73M | ﹤0.01% | 1742 |
|
|
2021
Q4 | $2.52M | Sell |
32,381
-17,947
| -36% | -$1.58M | ﹤0.01% | 2339 |
|
|
2021
Q3 | $4.8M | Sell |
50,328
-10,288
| -17% | -$1.09M | 0.01% | 1732 |
|
|
2021
Q2 | $7.54M | Buy |
60,616
+19,444
| +47% | +$2.32M | 0.01% | 1321 |
|
|
2021
Q1 | $5.43M | Sell |
41,172
-11,373
| -22% | -$1.56M | 0.01% | 1448 |
|
|
2020
Q4 | $6.96M | Buy |
52,545
+41,189
| +363% | +$4.98M | 0.01% | 1053 |
|
|
2020
Q3 | $1.16M | Buy |
+11,356
| New | +$981K | ﹤0.01% | 2064 |
|
|
2019
Q1 | – | Sell |
-46,207
| Closed | -$3.93M | – | 4964 |
|
|
2018
Q4 | $2.92M | Buy |
46,207
+2,214
| +5% | +$152K | 0.03% | 779 |
|
|
2018
Q3 | $3.47M | Buy |
43,993
+41,305
| +1,537% | +$2.69M | 0.03% | 795 |
|
|
2018
Q2 | $161K | Sell |
2,688
-72,356
| -96% | -$3.89M | ﹤0.01% | 3217 |
|
|
2018
Q1 | $3.03M | Buy |
75,044
+31,683
| +73% | +$1.55M | 0.03% | 731 |
|
|
2017
Q4 | $2.28M | Sell |
43,361
-15,862
| -27% | -$847K | 0.02% | 1108 |
|
|
2017
Q3 | $2.79M | Buy |
+59,223
| New | +$2.38M | 0.03% | 851 |
|
|
2017
Q1 | – | Sell |
-163,691
| Closed | -$3.24M | – | 4725 |
|
|
2016
Q4 | $2.19M | Sell |
163,691
-75
| -0% | -$1.21K | 0.02% | 870 |
|
|
2016
Q3 | $3.04M | Sell |
163,766
-4,020
| -2% | -$70.8K | 0.03% | 627 |
|
|
2016
Q2 | $2.06M | Buy |
167,786
+89,909
| +115% | +$677K | 0.02% | 816 |
|
|
2016
Q1 | $525K | Sell |
77,877
-48,756
| -39% | -$312K | 0.01% | 1647 |
|
|
2015
Q4 | $1.17M | Sell |
126,633
-5,012
| -4% | -$46.6K | 0.01% | 1209 |
|
|
2015
Q3 | $2.37M | Sell |
131,645
-49,840
| -27% | -$1.14M | 0.03% | 688 |
|
|
2015
Q2 | $5.4M | Buy |
+181,485
| New | +$4.56M | 0.08% | 298 |
|
|
2014
Q4 | – | Sell |
-65,888
| Closed | -$1.6M | – | 5003 |
|
|
2014
Q3 | $1.28M | Buy |
+65,888
| New | +$1.21M | 0.02% | 944 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Group One Trading's EXAS Position: Q3 2024 in Review
Group One Trading sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 29,726 shares — an estimated $1.68M sold.
Group One Trading first reported a position in EXAS in Q3 2014 and held it in 28 quarters. The position peaked at $7.54M in Q2 2021. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.
- Group One Trading reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
- Group One Trading sold 29,726 Exact Sciences shares in Q3 2024, an estimated $1.68M.
- Group One Trading first reported a position in Exact Sciences in Q3 2014 and held it in 28 quarters.
- Group One Trading's Exact Sciences position peaked at $7.54M in Q2 2021.
- 599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.
Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.